GB1908 is a selective and orally active galectin-1 inhibitor with K i values of 57 nM and 72 nM for human and mouse galectin-1 , respectively. GB1908 displays >50-fold selectivity over galectin-3 . GB1908 can be used for the study of lung cancer .
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Galectin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.